Acquisitions and Other Transactions (Jai Pharma Limited) (Narrative) (Details)	Nov. 20, 2015 USD ($) shareholder		Mar. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)
Business Acquisition [Line Items]
Goodwill			$ 5,566,900,000	$ 5,380,100,000
Jai Pharma Limited
Business Acquisition [Line Items]
Acquisition purchase price	$ 750,000,000
Net assets acquired	$ 711,100,000	[1]	711,100,000
Minimum number of former shareholders providing services | shareholder	1
Number of shareholders | shareholder	2
Post-acquisition consulting services period, in years	2 years
Working capital and other adjustments excluded	$ (7,000,000)
Purchase consideration, contingent consideration arrangements	18,000,000
Goodwill	317,200,000	[1]	325,300,000
Amount of goodwill expected to be tax deductible			$ 0
Jai Pharma Limited | Maximum
Business Acquisition [Line Items]
Purchased consideration, contingent consideration, maximum	$ 50,000,000

[1] As previously reported in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015, as amended.